Biocon Limited announced changes following its 48th Annual General Meeting (AGM) held on August 6, 2026. Mr. Eric Vivek Mazumdar was re-appointed as a director, while Mr. Nicholas Robert Haggar completed his term as an independent director. The company also appointed S.R. Batliboi & Associates LLP as its new statutory auditors for a five-year term, replacing B S R & Co. LLP.
Biocon Limited Announces Key Governance Changes Post-AGM
Biocon Limited has officially disclosed significant changes in its directorial and statutory auditor roles subsequent to its 48th Annual General Meeting (AGM). The AGM took place on Thursday, August 06, 2026, conducted via video conferencing and other audio-visual means.
Director Appointments and Retirements
Following the procedures of the meeting, Mr. Eric Vivek Mazumdar (DIN: 09381549) has been re-appointed as a Director, subject to retirement by rotation. In line with the completion of his tenure, Mr. Nicholas Robert Haggar (DIN: 08518863) has retired as an Independent Director.
New Statutory Auditor Appointed
In addition to the director changes, the company has appointed a new statutory auditor. S.R. Batliboi & Associates LLP, Chartered Accountants, with Firm Registration No. 101049W/E300004, will serve as the Statutory Auditors. This appointment is for a term of five consecutive years, commencing from the conclusion of the 48th AGM and extending until the conclusion of the 53rd AGM, scheduled for the year 2031. This appointment replaces the retiring statutory auditors, B S R & Co. LLP, whose term expired at the conclusion of the 48th AGM.
Director Compliance Confirmation
Biocon Limited also confirmed that, in adherence to circulars issued by stock exchanges, Mr. Eric Vivek Mazumdar is not debarred from holding a directorial position by any order from the Securities and Exchange Board of India (SEBI) or any other relevant authority.
Further Details Available
Additional details required under the SEBI Listing Regulations, read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are provided in ‘Annexure A’. This intimation is also accessible on the company’s website.
Source: BSE
